ACIP Issues 2021 Immunization Schedule for Adults
FRIDAY, Feb. 12, 2021 -- The recommended immunization schedule for adults has been updated for 2021, according to a report published online Feb. 11 in the Annals of Internal Medicine and in the Feb. 12 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Mark S. Freedman, D.V.M., from the CDC in Atlanta, and colleagues present the 2021 adult immunization schedule, which summarizes the Advisory Committee on Immunization Practices (ACIP) recommendations.
The 2021 immunization schedule includes several changes from the 2020 schedule on the coverage page, two tables, and accompanying notes. Vaccine-specific changes include new or updated ACIP recommendations for influenza vaccine, hepatitis A vaccine, hepatitis B vaccine, human papillomavirus vaccine, pneumococcal vaccines, meningococcal serogroups A, C, W, and Y vaccines, meningococcal B vaccines, and zoster vaccine. In addition, a section has been added for COVID-19 vaccine recommendations, following interim recommendations for use of Pfizer-BioNTech and Moderna COVID-19 vaccines after emergency use authorization by the U.S. Food and Drug Administration. Other updates include changes to Table 2 to indicate that the measles, mumps, and rubella vaccine should be administered after pregnancy; the varicella vaccine should be administered after pregnancy; and the zoster vaccine live or Zostavax vaccine has been removed since it is no longer available in the United States.
"For further guidance on the use of each vaccine, including contraindications and precautions, and any updates that might occur between annual updates to the adult immunization schedule, health care providers are referred to the respective ACIP vaccine recommendations," the authors write.
© 2021 HealthDay. All rights reserved.
Posted: February 2021
Read this next
THURSDAY, Feb. 25, 2021 -- There is underrepresentation of racial/ethnic minorities and older patients among U.S.-based vaccine clinical trials, while female adults are...
WEDNESDAY, Feb. 24, 2021 -- A single-shot COVID-19 vaccine made by Johnson & Johnson completely prevented hospitalizations and deaths in a large clinical trial, according to...
WEDNESDAY, Feb. 24, 2021 -- The BNT162b2 mRNA vaccine is effective for COVID-19-related outcomes, including hospitalization, severe illness, and death, in a nationwide, mass...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.